JAMA & ARCHIVES
Arch Fam Med
SEARCH
GO TO ADVANCED SEARCH
HOME  PAST ISSUES  TOPIC COLLECTIONS  CME  PHYSICIAN JOBS  CONTACT US  HELP
Institution: CLOCKSS  | My Account | E-mail Alerts | Access Rights | Sign In
  Vol. 8 No. 4, July 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Special Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (10)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal

The "Prescription-to-OTC Switch" Movement

Its Effects on Antifungal Vaginitis Preparations

Martin S. Lipsky, MD; Theresa Waters, PhD

Arch Fam Med. 1999;8:297-300.

More than 600 over-the-counter (OTC) products have ingredients or dosages that were previously available by prescription only. The criteria for switching drugs include a low potential for misuse or abuse, safety and efficacy, and the ability for effective use by the average person. In addition, the conditions the drugs treat should be benign and self-limited. In 1990, the first topical imidazole for candidal vaginitis was approved by the Food and Drug Administration for over-the-counter use. Suggested benefits of this switch were increased patient autonomy and reduced costs. Risks include potential for misdiagnoses, resulting in inappropriate use, unnecessary use, or delay in treatment, which could lead to increased cost and morbidity. Despite the wide use of these products, there is little evidence examining the outcome of the switch. Limited available data suggest that the switch of the antifungal preparations reduces costs with little objective evidence of harm resulting from the switch.


From the Department of Family Medicine, Northwestern University Medical School, Chicago, Ill (Dr Lipsky), and the Institute for Health Services Research and Policy Studies, Northwestern University, Evanston, Ill (Dr Waters).


RELATED ARTICLE

The Archives of Family Medicine Continuing Medical Education Program
Arch Fam Med. 1999;8(4):291-293.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

ASHP statement on criteria for an intermediate category of drug products.
Am J Health Syst Pharm 2009;66:502-505.
FULL TEXT  

Variability of Vaginal pH Determination by Patients and Clinicians.
Ferris et al.
J Am Board Fam Med 2006;19:368-373.
ABSTRACT | FULL TEXT  

Changing the Status of Drugs from Prescription to Over-the-Counter Availability
Brass
NEJM 2001;345:810-816.
FULL TEXT  




HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.